No Data
No Data
KeyBanc Maintains Ardent Health Partners(ARDT.US) With Buy Rating, Maintains Target Price $24
Analysts' Opinions Are Mixed on These Healthcare Stocks: Standard BioTools (LAB) and Ardent Health Partners, Inc. (ARDT)
Ardent Health Partners GAAP EPS of $0.81 Beats by $0.36, Revenue of $1.61B Beats by $130M
ARDENT HEALTH PARTNERS Earnings Results: $ARDT Reports Quarterly Earnings
Express News | Ardent Health Partners Inc Outlook 2025 Capital Expenditures $215 - $235 Mln
Express News | Ardent Health Partners Shares Are Trading Higher After the Company Reported Better-than-expected Q4 Financial Results